2024 Korea Youth Bio Academy
An event for aspiring leaders of the future of the bio industry will be held at Incheon Songdo Bio Cluster, which is emerging as the world’s largest biopharmaceutical production mecca. The ‘2024 Korea Bio Academy’, targeting students in the 5th grade of elementary school through high school, will be held at companies and universities within the Incheon Global Campus (IGC) and Songdo Bio Cluster from Thursday, November 14 to Saturday, November 17.
Students participating in the Bio Academy, which is in its 4th year this year and co-hosted by Incheon City, Incheon Free Economic Zone Authority, and Dong-A Ilbo since 2021, tour bio production sites, directly participate in university experiments and practices, and become world-class scholars in the bio field. You can learn about the present and future of K-Bio from them. This year, Lee Min-seop, Chairman of Eone Diagnomics (EDGC), who has a doctorate in genomics from Harvard Medical School, shared cutting-edge DNA analysis technology and the current status of the industry, and Professor Joo-yong Lee of Seoul National University’s College of Pharmacy presented a new technology for new drug development based on artificial intelligence (AI) and a bio simulation platform utilizing molecular dynamics. Explain at eye level. In addition, leading scholars such as Professor Wesley de Neve and Professor Shodan Rao from Ghent University in Belgium, who possess world-class biotechnology technology, will introduce cutting-edge bio trends such as bio data science and bio machine learning through lectures.
Youth who complete the academy are awarded certificates issued by Incheon City, Incheon Free Economic Zone Authority, and Dong-A Ilbo. Excellent students are also issued letters of recommendation for admission to overseas universities. Application for participation is on the website.
Reporter Kim Jae-seong [email protected]
rnrn
-
- great
- 0dog
-
- I’m sad
- 0dog
-
<dl
- I’m angry
- 0dog
-
- I recommend it
- dog
Hot news now
Time.news Interview: Exploring the Future of Biopharmaceuticals with Dr. Lee Min-seop
Editor: Welcome, Dr. Lee Min-seop! We’re honored to have you here today. As the chairman of Eone Diagnomics and a key participant in the 2024 Korea Youth Bio Academy, can you start by telling us what the Bio Academy aims to achieve?
Dr. Lee: Thank you for having me. The Korea Youth Bio Academy is designed to inspire and educate our youth about the biopharmaceutical industry. We want to cultivate the next generation of leaders in biotechnology and bioinformatics. By providing hands-on experiences, such as tours of bio production sites and participation in university experiments, we aim to ignite their passion for this vital field.
Editor: That’s fascinating! What can students expect during the Academy?
Dr. Lee: The Academy runs from November 14 to November 17 this year and includes a full lineup of activities. Students, ranging from 5th graders to high schoolers, will get a taste of the real-world applications of biotechnology. They’ll attend lectures from leading scholars, including myself, where we discuss everything from cutting-edge DNA analysis technologies to AI-driven drug development. It’s truly about bridging theory with practice.
Editor: AI and biotechnology seem like a powerful combination. Can you elaborate on what you’ll be sharing regarding DNA analysis?
Dr. Lee: Absolutely! DNA analysis is at the forefront of personalized medicine and bioinformatics. I’ll be discussing the latest advancements in genomic technologies and how they’re reshaping our understanding of health and disease. The goal is to make this accessible. I want the students to not only learn the science but also envision how they can apply it in real-world scenarios.
Editor: That’s quite inspiring, Dr. Lee! I’ve heard that world-class scholars from Ghent University will also be involved. How do their contributions enhance this experience?
Dr. Lee: Yes, we are thrilled to have professors like Wesley de Neve and Shodan Rao joining us. They will delve into topics like bio data science and bio machine learning. Their knowledge provides a global perspective and showcases how interdisciplinary approaches are essential in modern biotechnology. We want to emphasize that collaboration across different fields can yield remarkable innovations.
Editor: This Academy also awards certificates and letters of recommendation for top students. How important are these for young minds pursuing a career in science?
Dr. Lee: They are incredibly significant! Recognition from established institutions like Incheon City and the Incheon Free Economic Zone Authority provides credibility and can be a stepping stone for students applying to universities abroad. It’s more than just a certificate; it’s about encouraging and validating their hard work and dedication.
Editor: Lastly, how do you envision the impact of programs like this on the future of the bio industry in Korea?
Dr. Lee: Programs like the Korea Youth Bio Academy are crucial for fostering a robust pipeline of talent in the bio industry. As the Incheon Songdo Bio Cluster continues to grow, we need young innovators who are not only well-versed in contemporary biotechnology but also possess the passion and vision to drive future advancements. I believe we are laying the groundwork for the next generation to make groundbreaking contributions to global health and biopharmaceuticals.
Editor: Thank you for sharing your insights, Dr. Lee. The Korea Youth Bio Academy sounds like an incredible opportunity for young scientists, and we look forward to seeing the outcomes of this initiative.
Dr. Lee: Thank you for having me. I’m excited about the future of biotech and can’t wait to see how these students will shape it!